Home > Magazine > Society

Conquer Cancer Foundation Announces Steven T. Rosen, MD, FACP, as Newest Board Member

Oct 29, 2013

 Steven T. Rosen, MD,
The Conquer Cancer Foundation of ASCO's mission to fund breakthrough research and share cuttingedge knowledge is supported by the depth and breadth of expertise represented in its 16-member Board of Directors. This year, the Foundation has named internationally renowned oncologist Steven T. Rosen, MD, FACP, as the newest Board member.

Conquer Cancer Foundation 
Board of Directors

W. Charles Penley, MD, FASCO*

Gabriel N. Hortobagyi, MD, FACP, FASCO*

John H. Glick, MD, FASCO*

Allen S. Lichter, MD, FASCO
ASCO CEO and CCF CEO (ex-officio)

Clifford A. Hudis, MD, FACP
ASCO President (ex-officio)

Nancy R. Daly, MS, MPH
Executive Director (ex-officio)

Lawrence H. Einhorn, MD, FASCO

Ira M. Elegant, Esq.

Michael L. Gordon, JD

Beth Y. Karlan, MD*

Thomas A. Marsland, MD, FASCO

Robert J. Mayer, MD, FASCO

Martin J. Murphy, DMedSc, PhD, FASCO
Chair Emeritus

Thomas G. Roberts, Jr., MD

Steven T. Rosen, MD, FACP

Sandra M. Swain, MD, FACP*

*Designates members who are returning
for another term
"It is an honor to welcome Dr. Steven Rosen to the Conquer Cancer Foundation Board leadership," said W. Charles Penley, MD, FASCO, Chair of the Foundation's Board of Directors. "Dr. Rosen has made significant contributions to the cancer community throughout his life and career, and we are fortunate to be able to draw on his passion and expertise as we seek to advance our vision—a world free from the fear of cancer."

A globally recognized figure in cancer care, Dr. Rosen is the Genevieve E. Teuton Professor of Medicine and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Dr. Rosen's research team has advanced novel agents and technologies for the management of patients with blood cancers. He is also the current Co-Principal Investigator of Northwestern's NCI-funded Center for Cancer Nanotechnology Excellence, overseeing the clinical and biologic components of the grant.

Dr. Rosen has served in an advisory capacity to the National Cancer Institute and more than 20 distinguished cancer centers across the nation. He has also served on numerous editorial boards and is current Editor-in-Chief for Cancer Treatment & Research.

Despite Dr. Rosen's enormous research and editorial undertakings, he continues to provide primary oncology care to patients with hematologic malignancies and breast cancer, and he is listed as both one of "Chicago's Top Doctors" and "America's Top Doctors." Dr. Rosen has also been recognized with honors including the "Martin Luther King Humanitarian Award," from the Northwestern Memorial Hospital, and the distinguished "Alumni Merit Award" from Northwestern University.

Dr. Rosen joins the exceptional group of leaders who serve on the Conquer Cancer Foundation's Board of Directors. See the sidebar for the complete list of current Board members, including members who have been re-elected for a second term. For full bios of all of the Board members, visit conquercancerfoundation.org/board.

Back to Top